News Detail
Ohio, 7 Dec 2023: The first acute kidney injury (AKI) biomarker test to receive U.S. Food and Drug Administration 510(k) clearance for pediatric use in the United States was discovered here at Cincinnati Children’s.View Details
Source : Cincinnati Children’s
kidney injury (AKI) biomarker test
Cincinnati Children’s
neutrophil gelatinase-associated lipocalin (NGAL) test
ProNephro AKI test
Related News
- Stent not Removed After PCNL: Hospital, surgeon Slapped Rs 35 Lakh Compensation for Deficiency in Service (05-11-2024)
- Philippines: Fake child vitamins 'produced in washing machine' (05-11-2024)
- CDSCO may regulate health supplements (05-11-2024)
- Malda: 2,400 bottles of phensedyl seized (05-11-2024)
- US Court blocks Sun Pharma's LEQSELVI launch, Grants preliminary injunction amid patent dispute (04-11-2024)
- Ayush Ministry amends Rules to mandate renewal of licenses perpetuity (04-11-2024)
- Procedural lapse in NDPS cases can violate fundamental rights: High Court (04-11-2024)
- FSSAI sets stricter rule for antibiotics in food items (04-11-2024)
- Pregnant woman suffered ruptured uterus and blood turned toxic after pills, RMP under lens (04-11-2024)
- Dr Reddy’s recalls over 3 lakh bottles of Cinacalcet tablets in US due to manufacturing issues (03-11-2024)